1. Home
  2. BAK vs SPTX Comparison

BAK vs SPTX Comparison

Compare BAK & SPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Braskem SA ADR

BAK

Braskem SA ADR

HOLD

Current Price

$2.45

Market Cap

1.2B

Sector

Industrials

ML Signal

HOLD

Logo Seaport Therapeutics Inc. Common Stock

SPTX

Seaport Therapeutics Inc. Common Stock

N/A

Current Price

$21.27

Market Cap

1.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BAK
SPTX
Founded
1972
N/A
Country
Brazil
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.1B
IPO Year
2002
2026

Fundamental Metrics

Financial Performance
Metric
BAK
SPTX
Price
$2.45
$21.27
Analyst Decision
Hold
Analyst Count
2
0
Target Price
$4.40
N/A
AVG Volume (30 Days)
2.1M
124.7K
Earning Date
05-12-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$16.02
N/A
Revenue Next Year
$7.04
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.25
$17.59
52 Week High
$5.40
$22.98

Technical Indicators

Market Signals
Indicator
BAK
SPTX
Relative Strength Index (RSI) 40.11 58.35
Support Level $2.32 $18.47
Resistance Level $2.78 $22.12
Average True Range (ATR) 0.14 1.76
MACD 0.05 0.04
Stochastic Oscillator 40.20 74.03

Price Performance

Historical Comparison
BAK
SPTX

About BAK Braskem SA ADR

Braskem SA is engaged in the manufacture, sale, import and export of chemicals, petrochemicals and fuels, as well as the production, supply and sale of utilities such as steam, water, compressed air and industrial gases. It also provides industrial services and is engaged in the production, supply and sale of electric energy and gas for its own use and use by other companies. Its segments include Brazil, USA and Europe; and Mexico. The Brazil segments delivered the majority of the revenue from the production and sale of chemicals; the supply of electricity and other inputs produced in these complexes to second-generation producers located in the petrochemical complexes; and the production and sale of PE, including the production of green PE made from renewable resources, and of PP.

About SPTX Seaport Therapeutics Inc. Common Stock

Seaport Therapeutics Inc is a clinical-stage therapeutics company. The company focuses on invention and development of new medicines for patients with depression, anxiety, and other debilitating neuropsychiatric disorders. The company identified clinically validated mechanisms with established efficacy and safety profiles, historically limited by high first-pass metabolism, low bioavailability, and side effects. The company's pipeline products are based on Glyph, company's lymphatic-targeting prodrug technology is designed to bypass first-pass metabolism and thereby enhance a drug's oral bioavailability and reduce side effects.

Share on Social Networks: